Spinal Cord Injury: Cannabis Research
Overview
Spinal cord injury (SCI) refers to any injury to the spinal cord that is caused by trauma instead of disease. Five patients with traumatic paraplegia were given oral Delta-9-THC at 35 mg/day in a double blind, 20-day crossover trial.

Video
Cannabis to Manage Symptom Burden in Spinal Cord Injury
Cannabis to Manage Symptom Burden in Spinal Cord Injury
Cannabis Medical Journals
2013 - Study ~ Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats
2013 - Study ~
A new co-ultramicronized composite including palmitoylethanolamide and
luteolin to prevent neuroinflammation in spinal cord injury
2013 - Study ~ Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries
2013 - Study ~ Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator
2013 - Study ~ Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats.
2012 - Study ~ Early
Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury
Is a Protective Response Involved in Spontaneous Recovery
2012 - Study ~ A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord
2012 - Study ~ Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury
2011 - Study ~ Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases.
2011 - Study ~ Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury.
2011- Study ~ Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury.
2011 - Study ~ Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury.
2011- Study ~ Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury.
2011 - Study ~ Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.
2010 - Study ~ Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain.
2010 - Study ~ Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study.
2010 - Study ~ Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
2010 - Study ~ The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.
2010 - Study ~ A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury.
2009 - Study ~ The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function.
2008 - Study ~ Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury.
2006 - Study ~ Treatments for Chronic Pain in Persons With Spinal Cord Injury: A Survey Study.
2006 - Study ~ Antinociceptive effect of cannabinoid agonist WIN 55,212–2 in rats with a spinal cord injury.
2006 - Study ~ Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain.
2006 - Study ~ Cannabinoids In Medicine: A Review Of Their Therapeutic Potential.
2006 - Study ~ The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury.
2003 - Study ~ The treatment of spasticity with D9-tetrahydrocannabinol (D9-THC) in patients with spinal cord injury.
2003 - Study ~ Therapeutic potential of cannabinoids in CNS disease.
2004 - Study ~ Are oral cannabinoids safe and effective in refractory neuropathic pain?
2001 - Study ~ Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo.
1999 - Study ~ Cannabis and cannabinoids: pharmacology and rationale for clinical use.
1997 - Study ~ Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord.
1996 - Study ~ The effect of orally and rectally administered delta-9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
1995 - Study ~ Treatment of spasticity in spinal cord injury with dronabinol, a tetrahydrocannabinol derivative.
1990 - Study ~ Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.
1986 - Study ~ The effect of delta-9-THC on human spasticity.
1982 - Study ~ Cannabis effect on spasticity in spinal cord injury.
1980 - Study ~ Marihuana as a therapeutic agent for muscle spasm or spasticity.
1974 - Study ~ The perceived effects of marijuana on spinal cord injured males.